Brief: Orthofix Announces First Clinical Use Of Virtuos Lyograft
26/07/2022 12:33
July 26 (Reuters) - Orthofix Medical Inc OFIX.O :
* ORTHOFIX ANNOUNCES FIRST CLINICAL USE OF VIRTUOS LYOGRAFT
– A
FIRST-OF-ITS-KIND, SHELF-STABLE AND COMPLETE AUTOGRAFT
SUBSTITUTE FOR SPINE AND ORTHOPEDIC PROCEDURES
Source text for Eikon: ID:nBw5pBqHla
Further company coverage: OFIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orthofix Medical
See all newsOrthofix Medical Inc. reports results for the quarter ended June 30 - Earnings Summary
Orthofix Medical Q2 sales slightly beat estimates
Orthofix Medical Inc expected to post a loss of 41 cents a share - Earnings Preview
Orthofix Medical Q1 sales beat estimates, reaffirms FY outlook
Brief: Orthofix Medical Inc - Announces Strategic Realignment Of Spine Leadership Team